Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 803 results for "new england journal of medicine"

Why Using Your Phone In Bed Can Cause Temporary Blindness, Even After You Get Up
Life Hacker India

Can checking your smartphone in the dark make you blind?

A recent case from the New England Journal of Medicine talks about two women who went temporarily blind because of using their smartphones in the dark. DNA, 1 month ago
Smartphone 'Blindness' Diagnosed in 2 Women Equilibrio Informativo, 2 weeks ago

91 images for new england journal of medicine

PharmaVOICE, 2 weeks ago
Deccan Chronicle, 3 weeks ago
Deccan Chronicle, 1 month ago
Forwardgeek, 2 weeks ago
BioSpace, 6 days ago
Yahoo! Singapore, 6 days ago
Bangalore Mirror, 3 weeks ago
Deccan Chronicle, 3 months ago
Deccan Chronicle, 3 months ago
Deccan Chronicle, 3 months ago

Medical journalist describes slow journey to recovery from traumatic brain injuries

Eleven years ago in the New England Journal of Medicine, medical journalist Susan Okie, MD, first introduced readers to two U.S. Army veterans who suffered traumatic brain injuries in Iraq, and the challenges they faced in the recovery period after ...
 News-Medical.Net1 week ago NEJM: 'TBI's long-term follow-up -- slow progress in science and recovery' Georgetown University Medical Center 12m  EurekAlert!2 weeks ago NEJM: "TBI's Long-Term Follow-Up -- Slow Progress in Science and Recovery"  Infrosoft1 week ago
PharmaVOICE

PUMA BIOTECHNOLOGY : Announces I-SPY 2 Phase II Study of Neratinib Published in The New England Journal of Medicine

Puma Biotechnology, Inc. (NYSE: PBYI), a biopharmaceutical company, announced that the positive results from the I-SPY 2 Phase II clinical trial of neratinib for the neoadjuvant treatment of breast cancer were published in the July 7 issue of The ...
 4 Traders2 weeks ago Puma Biotechnology Announces I-SPY 2 Phase II Study of Neratinib Published in The New England Journal of Medicine  TMC Net2 weeks ago Puma Biotech Announces I-SPY 2 Phase II Study Of Neratinib Published In The New England Journal of Medicine  BioSpace2 weeks ago
[x]  
Forwardgeek

Cytel Publication in the New England Journal of Medicine Propels Adaptive Design into the Mainstream of Medical Research

Cytel publication in New England Journal of Medicine propels adaptive clinical trial designs into the mainstream of medical research. Cytel Inc., a provider of clinical research services and software to the biopharmaceutical industry and pioneer ...
 Minyanville2 weeks ago
[x]  

Olanzapine helps prevent nausea in patients on chemo

0 Flares 0 Flares × FROM THE NEW ENGLAND JOURNAL OF MEDICINE Olanzapine is more effective than placebo, in combination with a 5-HT3-receptor antagonist and an NK1-receptor antagonist, in preventing nausea in patients undergoing ...
 PM 3601 week ago Olanzapine prevents nausea in patients treated with emetogenic chemotherapy  Healio1 week ago

Ipilimumab may restore antitumor immunity after relapse from HSCT

FROM THE NEW ENGLAND JOURNAL OF MEDICINE Early data hint that immune checkpoint inhibitors may be able to restore antitumor activity in patients with hematologic malignancies that have relapsed after allogeneic transplant. Among 22 patients ...
 PM 3601 week ago

Flowtech System Detects Gas & CO Leaks

According to a few different sources that include the FDNY, the CDC, and the New England Journal of Medicine, nearly 70 percent of all fire department responses are for gas leaks; 450 people are killed annually by carbon monoxide (CO) poisoning, and ...
 ElectronicHouse2 weeks ago
MedIndia

Malaria vaccine disappoints in phase II trial

FROM THE NEW ENGLAND JOURNAL OF MEDICINE The efficacy of an investigational malaria vaccine waned from 36% to 2.5% over a period of 7 years in Kenya, at which time it was even associated with an excess of cases in areas of high malaria ...
 PM 3603 weeks ago Malaria vaccine loses effectiveness over several years: study  SAMAA TV2 weeks ago Eugenicist Bill Gates Crappy Malaria Vaccine Is Admittedly Only 4% Effective  Before It's News3 weeks ago Malaria Vaccine RTS, S/AS01: Results of a Seven Year Study  MedIndia3 weeks ago
[x]  

Novartis issues favourable results for PKC412 (midostaurin) study

Andrew Schonberg (ShareCast News) - Novartis said The New England Journal of Medicine (NEJM) has published data for an PKC412 (midostaurin) study that showed an overall response rate of 60% in patients with advanced systemic mastocytosis (SM). The ...
 BullBearings3 weeks ago NOVARTIS : PKC412 midostaurin pivotal data published in NEJM show 60% response rate in advanced systemic mastocytosis SM  4 Traders2 weeks ago
[x]  

Chocolate: food for the soul . . . and the body

If only my late mother had subscribed to the Journal of the American Medical Association. I forgive the old girl this lapse there were few working-class JAMA subscribers in 1970s Belfast. Still, Mum would have learned that chocolate neither causes ...
 Irish Times1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - new england journal of medicine
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less